CHAPTER 1 INTRODUCTION

1.1 Report description
1.2 Research methodology

1.2.1 Secondary Research
1.2.2 Primary research
1.2.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO perspective

CHAPTER 3 MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key findings

3.2.1 Top investment pockets

3.3 Porters Five Forces Analysis
3.4 Market Dynamics

3.4.1 Drivers

3.4.1.1 Support from healthcare organizations
3.4.1.2 Rising pregnancy complications
3.4.1.3 Technological advancements

3.4.2 Restraints

3.4.2.1 Dearth of trained healthcare providers
3.4.2.2 High cost of the devices

3.4.3 Opportunities

3.4.3.1 Drugs failure

3.5 Clinical Trials
3.6 Government Guidelines and Recommendations

CHAPTER 4 WORLD POSTPARTUM HEMORRHAGE DEVICES MARKET, BY PRODUCT

4.1 Overview

4.1.1 Market size and forecast

4.2 Non pneumatic anti-shock garment (NASG)

4.2.1 Key market trends
4.2.2 Growth factors and opportunities
4.2.3 Market size and forecast

4.3 Uniject prefilled injection system

4.3.1 Key market trends
4.3.2 Growth factors and opportunities
4.3.3 Market size and forecast

4.4 Uterine balloon tamponade

4.4.1 Key market trends
4.4.2 Growth factors and opportunities
4.4.3 Market size and forecast

4.4.3.1 Foley catheter
4.4.3.2 Market size and forecast
4.4.3.3 Condom catheter
4.4.3.4 Market size and forecast
4.4.3.5 Bakri balloon tamponade
4.4.3.6 Market size and forecast
4.4.3.7 Rusch balloon
4.4.3.8 Market size and forecast
4.4.3.9 BT-Cath balloon
4.4.3.10 Market size and forecast

CHAPTER 5 WORLD POSTPARTUM HEMORRHAGE DEVICES MARKET, BY GEOGRAPHICAL PRESENCE

5.1 Overview

5.1.1 Market size and forecast

5.2 North America

5.2.1 Key market trends
5.2.2 Key growth factors and opportunities
5.2.3 Market size and forecast
5.2.4 U.S. market size and forecast
5.2.5 Canada market size and forecast
5.2.6 Mexico market size and forecast

5.3 Europe

5.3.1 Key market trends
5.3.2 Key growth factors and opportunities
5.3.3 Market size and forecast
5.3.4 Germany market size and forecast
5.3.5 France market size and forecast
5.3.6 U.K. market size and forecast
5.3.7 Italy market size and forecast
5.3.8 Netherlands market size and forecast
5.3.9 Ukraine market size and forecast
5.3.10 Spain market size and forecast
5.3.11 Rest of Europe market size and forecast

5.4 Asia Pacific

5.4.1 Key market trends
5.4.2 Key growth factors and opportunities
5.4.3 Market size and forecast
5.4.4 Japan market size and forecast
5.4.5 China market size and forecast
5.4.6 India market size and forecast
5.4.7 Australia market size and forecast
5.4.8 South Korea market size and forecast
5.4.9 Indonesia market size and forecast
5.4.10 Rest of Asia-Pacific market size and forecast

5.5 LAMEA

5.5.1 Key market trends
5.5.2 Key growth factors and opportunities
5.5.3 Market size and forecast
5.5.4 Brazil market size and forecast
5.5.5 Nigeria market size and forecast
5.5.6 Turkey market size and forecast
5.5.7 Saudi Arabia market size and forecast
5.5.8 South Africa market size and forecast
5.5.9 Argentina market size and forecast
5.5.10 Rest of LAMEA market size and forecast

CHAPTER 6 COMPANY PROFILES

6.1 Utah Medical Products Inc.

6.1.1 Company overview
6.1.2 Operating business segments
6.1.3 Business performance

6.2 C. R. Bard, Inc.

6.2.1 Company Overview
6.2.2 Operating Business Segments
6.2.3 Business Performance
6.2.4 Key Strategic Moves & Developments

6.3 Cook Medical, Inc.

6.3.1 Company overview

6.4 Becton Dickinson and Company (Carefusion Corp.)

6.4.1 Company overview
6.4.2 Business performance

6.5 Teleflex Incorporated

6.5.1 Company overview
6.5.2 Operating business segments
6.5.3 Business performance

6.6 Bactiguard AB

6.6.1 Company overview
6.6.2 Operating business segments
6.6.3 Business performance
6.6.4 Key strategic moves & developments

6.7 Program for Appropriate Technology in Health (PATH)

6.7.1 Company overview
6.7.2 Operating business segments
6.7.3 Business performance

6.8 3RD Stone Design Inc.

6.8.1 Company overview
6.8.2 Operating business segments

6.9 ZOEX NIASG

6.9.1 Company overview

6.10 Inpress technologies

6.10.1 Company overview

*Other vendors considered in this market include Vitality Medical and RevMedx, Inc.